Registration Options

Activity Date: 04/19/2021

AAPP 2021 registration is closed.

Session Time and Location

The live session is complete.

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

There are many nuances to consider when evaluating the risks and benefits of antidepressant use in bipolar disorder (BD). Short-term efficacy of antidepressants for BD remains controversial and risks clinical worsening, especially in mixed states and with rapid-cycling. In this session, Drs. Goldberg and Nierenberg will debate the pros and cons of antidepressant use for BD treatment. Participants will hear evidence on both sides of the debate and gain insight to better equip them to make future treatment recommendations.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Attend and participate in the entire session and reflect upon its teachings.
  • Complete the evaluation at the end of the activity.
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Joseph F. Goldberg, MD
Andrew Nierenberg, MD

View biographical information and disclosures

Learning Objectives

  1. Outline the benefits and risks of antidepressant utilization in the treatment of bipolar disorder.
  2. Identify the risk of antidepressants to provoke treatment emergent affective switches in bipolar disorder and understand patient specific clinical characteristics that may influence antidepressant treatment outcomes.
  3. Describe data supporting or refuting the safety and efficacy of antidepressant use in bipolar disorder based on key meta-analyses.
  4. Discuss the strengths and limitations in the evidence base for antidepressants for bipolar disorder.

Continuing Education Credit and Disclosures

Activity Date: 04/19/2021
ACPE Contact Hours: 1
ACPE Number: 0284-0000-21-002-L01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.